Bgm Biological Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 46.79%
(FY 2023)
- Ebitda 46.79%
(FY 2023)
- Net Worth -19.90%
(FY 2023)
- Total Assets -0.02%
(FY 2023)
About Bgm Biological Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hare Deka and Mridu Hazarika serve as directors at the Company.
- CIN/LLPIN
U01403MP2009PTC022213
- Company No.
022213
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bgm Biological Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hare Deka  | Director | 31-Jul-2009 | Current |
| Mridu Hazarika | Director | 01-Jan-2013 | Current |
Financial Performance of Bgm Biological Laboratories.
Bgm Biological Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 46.79% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bgm Biological Laboratories?
In 2023, Bgm Biological Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Alirajpur Women Poultry Producer Company LimitedActive 6 years 8 months
Mridu Hazarika is a mutual person
- Maikal Women Layer Producer Company LimitedActive 7 years 4 months
Mridu Hazarika is a mutual person
- Kesla Women Poultry Producer Company LimitedActive 10 years 10 months
Mridu Hazarika is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bgm Biological Laboratories?
Unlock and access historical data on people associated with Bgm Biological Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bgm Biological Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bgm Biological Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
